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Transcriptional programs reveal how global gene ex-
pression is remodeled during changes in cell growth,
physiology, or environment. For example, the transcrip-
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lished for Drosophila development during metamorpho-Cambridge, Massachusetts 02139
sis (White et al., 1999). These expression profiles provide
a rich source of information for identifying genes that
may be coregulated and for modeling regulatory mecha-DNA microarray technologies permit systematic ap-
nisms and networks.proaches to biological discovery that have begun to
DNA array studies have also been designed to identifyhave a profound impact on biological research, pharma-
genes whose expression depends on a cell state orcology, and medicine. The ability to obtain quantitative
the functions of specific components of signaling orinformation about the complete transcription profile of
transcription apparatuses. In many cases, the naturecells promises to be an exceptionally powerful means
of these genes has led to new insights into biologicalto explore basic biology, diagnose disease, facilitate
processes. For example, studies designed to identifydrug development, tailor therapeutics to specific pathol-
genes whose expression depends on key componentsogies, and generate databases with information about
of the transcription initiation machinery in yeast led toliving processes. The new discipline of expression profil-
the insight that the general transcription apparatus ising will link many fields of biology and medicine with a
physically remodeled when cells encounter limiting nu-shared knowledge base and a common mathematical
trients (Holstege et al., 1998). The set of genes regulatedlanguage. However, major conceptual and technical
by genome ploidy in yeast revealed how ploidy canchallenges lie ahead in this rapidly evolving arena. This
influence cell cycle progression and explained whyreview highlights recent discoveries that come from the
greater cell size is associated with higher ploidies (Galit-use of microarray technologies and considers the revo-
ski et al., 1999). Specific genes associated with age-lutionary changes and challenges that lie ahead in
related phenotypes and diseases in humans have beenbiology.
identified, implicating mitotic misregulation in aging (Ly
et al., 2000).
DNA Microarray Technologies The value of such expression profiles has yet to be
Several different DNA microarray technologies are cur- fully realized, even by the investigators who produced
rently in use, some examples of which are shown in and published them. This limitation is due to the paucity
Figure 1. DNA arrays can be synthesized in situ with of computational tools necessary to analyze large data-
photochemical techniques or with ink jet technology sets, inadequate experience with modeling biological
(Marton et al., 1998; Lipshutz et al., 1999). Alternatively, problems and systems using large amounts of data,
prefabricated DNA molecules are printed in arrays on and the lack of methods for systematic experimental
glass slides or nylon membranes using robots (DeRisi examination of such models. Nonetheless, it is clear that
et al., 1997). Several of these technical platforms have expression profiles are remarkably robust signatures of
been put to the test with the complete set of yeast genes biological conditions. These signatures are a precise
and have produced expression data of sufficient quality molecular phenotype of the cell in a specific state. The
for biological discovery. Microarrays produced by each importance and utility of these signatures is illustrated
of these technologies will likely accommodate the entire by recent microarray-based studies into gene function
in yeast and classification of diseases in humans.population of genes carried within the human genome,
but improvements in microarray hardware, experimental
Gene Function and Drug Discoverydesign, and computational methods of analysis will need
Two issues of interest to biologists who wish to exploitto be made before the full potential of expression profil-
new genome sequence information have been examineding is obtained in mammalian cells. These issues will be
in a paper in this issue of Cell (Hughes et al., 2000). Thediscussed in more detail below.
first issue addressed by this work is whether expression
profiles of mutant cells can be used to accurately clas-
Transcriptional Programs sify the functions of previously uncharacterized genes.
DNA microarrays have been used to estimate the levels The second issue explored by these investigators is
of RNA species throughout the RNA population of living whether the expression profile of cells treated with a
cells and to explore transcriptional programs. The popu- pharmacological agent can be used to identify the target
lation of RNA species in a cell, the transcriptome, has of that drug. The evidence indicates that the function of
been estimated for yeast under certain growth condi- a gene can be accurately predicted from the expression
tions and, at least in part, for more complex eukaryotes profile of a cell with a mutation in that gene. The results
(Holstege et al., 1998; Lockhart and Winzeler, 2000). also provide an important proof-of-principle for new ap-
proaches to pharmacological research and develop-
ment.* E-mail: young@wi.mit.edu
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Figure 1. Selected DNA Microarrays
(a) Oligonucleotide array synthesized in situ with photochemical technology by Affymetrix. (b) Oligonucleotide array synthesized in situ with
ink-jet technology (Image courtesy of Rosetta Inpharmatics). (c) DNA microarray printed on a glass slide (Image courtesy of Corning, Inc).
The recent acquisition of genome sequences from Since the method works to classify genetic perturba-
tions, it should also be effective at identifying the func-substantial numbers of organisms (see http://www.
tional consequences of chemical perturbations. Indeed,ncbi.nlm.nih.gov/Genomes/index.html) has led to con-
the expression profiles obtained for drug-treated cellssiderable interest in methods that provide clues to the
are similar to profiles obtained when genes encodingfunctions of newly discovered genes. Functional anno-
the drug targets are mutated. The utility of this approachtation of genes has been approached in several ways.
to pharmaceutical research and development was dem-Gene function can be inferred from sequence homology
onstrated by identifying a previously unknown target ofamong predicted proteins, where the function of at least
the commonly used topical anesthetic dyclonine.one protein is known (Chervitz et al., 1998). Creative
It is possible to envision this new approach to func-computational methods have been developed that de-
tional annotation being extended to more complex or-tect functional linkages among predicted proteins (Ei-
ganisms. Mutagenesis screens in Drosophila, zebrafish,senberg et al., 2000). However, sequence analysis alone
and mouse, and the identification of large numbers ofis insufficient to fully inform us about gene function. The
rare single-gene disorders in man can contribute tomicroarray-based approach to this problem has been
functional annotation by this method. Chemical agentsto cluster genes according to their expression behavior
should be powerful probes to examine the functionsunder a range of conditions and to assign function ac-
of specific proteins and pathways in mammalian cells.cording to the set of known genes that fall into these
Given the substantial number of bioactive small-mole-clusters (Eisen et al., 1998; Tamayo et al., 1999). The
cule compounds currently available or under develop-premise with this guilt-by-association approach is that
ment for specific therapies, it is possible to imagine thatclustered genes may be coregulated and therefore be
ªchemical genomicsº will contribute significantly to ourinvolved in similar functions.
future understanding of the functions of some geneThe results described by Stephen Friend and col-
products.leagues (Hughes et al., 2000) indicate that gene function
Drug discovery in the last half century typically begancan be more accurately predicted from the expression
with a biochemical pathway implicated in a pathophysi-profile of a cell with a mutation in the gene of interest.
ological process. With sufficient information about the
These investigators developed a reference database of
enzymes that are critical for a functional pathway, bio-
yeast gene expression profiles for 300 different muta-
chemists and medicinal chemists collaborated to iden-
tions and chemical treatments. Since most of these mu- tify and optimize the therapeutic behavior of small mole-
tations and treatments affect well-understood cellular cules that bind to specific target enzymes. Clinical trials
functions, the expression profiles could be assigned to then identified the small molecules that have therapeutic
functional groups. The cellular pathways affected by a efficacy in human beings. This process now costs $50±
mutation in an uncharacterized gene could be ascer- $500 million for each new drug brought to market. DNA
tained by using pattern matching to compare the ex- microarray methods promise to make most steps in this
pression profile of cells harboring the mutation with process more precise and efficient. Indeed, microarray
those in the reference database. They identified and analysis is already being integrated into many steps in
experimentally confirmed functions for genes whose drug development, including target identification, target
products are involved in sterol metabolism, cell wall validation (demonstrating that affecting the enzyme or
function, mitochondrial respiration, and protein synthe- biochemical entity has therapeutic utility), optimizing ef-
sis. This approach has the advantage that genes exhib- ficacy and reducing toxicity (Debouck and Metcalf,
iting little transcriptional regulation can still be function- 2000; Roses, 2000). DNA microarray analysis may also
ally annotated if their mutation produces an expression facilitate identification of clinical trial participants who
signature that resembles signatures obtained with well- best respond or adversely react to specific therapeutics.
characterized genes. The power of the method is such
that it should lead to a more rigorous classification Disease Diagnosis, Prognosis, and Therapy
scheme than those currently employed to annotate gene Cancer and infectious diseases are major challenges to
the health of human populations, yet the techniquesfunctions in public databases.
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used to diagnose these diseases have changed little and other diseases with DNA microarray expression pro-
files underscore the importance of the collaboration be-in decades. New approaches have emerged from the
tween biology and computer science (Kahn et al., 1998;collaborative efforts of biologists, physicians, mathema-
Alon et al., 1999; Golub et al., 1999; Perou et al., 1999;ticians, and computer scientists involved in DNA mi-
Alizadeh et al., 2000; Ross et al., 2000). There is a richcroarray±based research into these diseases. More ac-
history of literature on classification algorithms that cancurate disease diagnosis and improvements in therapy
be used for predicting qualitative properties from DNAwill be the clinical benefit.
microarray data (Bishop, 1995). Such qualitative proper-Current cancer classification techniques rely on highly
ties can include diagnostic and prognostic indications.subjective judgments of tumor histology by patholo-
Classifiers require a training set of observations withgists. Multiple studies have demonstrated that DNA mi-
known classifications to establish appropriate modelscroarrays are useful for classifying human cancers and
and/or decision boundaries. The accuracy of a classifierhave revealed that expression profiles are valuable both
can be established with a validation set of observationsin cancer diagnosis and prognosis (Golub et al., 1999;
with known classifications, and the classifier can thenAlizadeh et al., 2000). This global quantitative approach
be applied to a set of observations with unknown classi-to classifying cancers and predicting outcomes will be-
fications. Clearly, the depth of our understanding of liv-come a valuable clinical tool for pathologists and oncol-
ing processes stands to gain by the marriage of biologyogists. DNA microarray analysis can allow physicians
and computation.to follow the progression of disease even when there is
no histological evidence of change. The ability to distin-
Complex Biological Systems
guish morphologically similar human cancers by the dif-
Deciphering the rules that govern complex systems is
ferences between their expression profiles is important the greatest challenge to scientists. Complex systems
because accurate identification of tumor types will facili- in biology include the transcriptional regulatory net-
tate matching the appropriate therapies, thereby max- works of living cells, the patterns of cell division and
imizing therapeutic efficacy and minimizing toxicity. The death that lead to development of multicellular organ-
information obtained through cancer classification will isms, the communication networks among the 100 bil-
almost certainly contain valuable clues to cancer mech- lion cells of the human brain, and the interactions be-
anisms and inspire new tactics to combat these dis- tween the vast numbers of living organisms that
eases. contribute to the ecology of the Earth's environment.
Infectious diseases are the major causes of global Just as Linnaean classification of living species contrib-
human morbidity and mortality. Indeed, infection has uted the groundwork necessary for the theory of natural
played a particularly important role in evolution and may selection, classification of living processes based on
be the most significant factor affecting the relative suc- expression profiles should contribute to profound im-
cess of human populations in history (McNeill, 1976; provements in our understanding of these processes.
Oldstone, 1998). The human population is continuously The elucidation of genome sequences and the devel-
threatened with newly emerging and increasingly drug- opment of technology for monitoring global gene ex-
resistant pathogens, many of which are difficult to cul- pression provide an opportunity to obtain informa-
tion on complex systems in cells and to initiate entirelyture and thus identify. Progress in understanding infec-
new fields of biological investigation. Reductionist ap-tious diseases and developing new therapies has been
proaches, first introduced by Rene Descartes in the mid-limited by the time-consuming approaches that have
1600s and clearly among the most powerful intellectualtraditionally been used to identify infectious agents, to
instruments in modern scientific discovery, have helpeddiscover their mechanisms of pathogenesis, and to ex-
biologists develop a fundamental understanding of anplore potential therapeutic approaches. PCR has led to
impressive array of basic features of cell and organismaluseful molecular diagnostic tools to identify new patho-
biology. The powerful combination of genetic and bio-gens (Relman et al., 1991) and to confirm diagnoses
chemical approaches has served biologists well and will(Rowley et al., 1990). The use of microarrays in infectious
continue to do so. The coupling of systems analysis anddisease research and classification, however, is likely
reductionist methods should prove to be even moreto produce revolutionary changes in this arena. It should
powerful. The models and hypotheses that emerge frombe possible to obtain signatures for pathogens that are
analysis of systemic expression information can be
diagnostic, even when the etiologic agent is not known
tested with genetic and biochemical methods.
or cannot be easily cultured. To obtain signatures for Hartwell, Hopfield, Leibler, and Murray have argued
specific pathogens, it will be necessary to capture their for recognition of functional modules as fundamental
effects on host cell gene expression. The best approach elements of biological organization and regulation be-
to analyzing patient material remains to be identified, cause most biological functions arise from interactions
but expression profiles of human macrophages infected among many components (Hartwell et al., 1999). A func-
by various viral and bacterial pathogens in the author's tional module, for example, might be the signal trans-
lab and elsewhere suggest the feasibility of this ap- duction system that converts the binding of pheromone
proach (Manger and Relman, 2000). Information ob- at the yeast cell surface into the act of mating. Under-
tained through pathogen classification by using signa- standing the structure and function of modules requires
tures from target cell populations will almost certainly more than analyzing properties of isolated components.
contain valuable clues to pathogenesis and potential The collection of precise information on global gene
new approaches to combat these diseases. expression as cells go about their business will be criti-
cal to understanding functional modules. The productThe approaches that are being used to classify cancer
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of this and other approaches should reveal general prin- Shared databases will facilitate communication among
scientists and physicians from different disciplines whociples governing the structure and behavior of modules.
Another new arena involves elucidating the regulatory have in the past used different experimental approaches,
analysis, and language (i.e., jargon). A more universallynetworks that govern gene expression. Just as knowl-
edge of biochemical pathways has been fundamental understood language will evolve to discuss experi-
ments, analysis, and interpretation of expression infor-to basic biology and to drug discovery, knowledge of
the regulatory networks that govern gene expression will mation.
Expression profiles will provide the basis for under-facilitate modeling of biological processes and efforts
to develop therapies for disorders and diseases. The standing how genes work together to guide the func-
tions of cells and organisms. Deciphering these regula-regulatory switch that governs the lysis versus lysogeny
decision of bacteriophage lambda has been modeled tory networks is attracting talent from many disciplines,
including biology, mathematics, physics, engineering,(Arkin et al., 1998), and biologists and computer scien-
tists are now exploring how to use genome-wide expres- and computer science. The task of deciphering regula-
tory networks will be substantial and will require sharedsion profiles to deduce models for the regulatory net-
works and circuitry of small genomes (Tavazoie et al., databases that contain our partial knowledge about reg-
ulatory networks in a standard framework. Such shared1999). The principled comparison of competing models
will be of critical importance as the complexity of such databases will be essential for the collaborations neces-
sary to elucidate regulatory networks and will be valu-models grows to encompass tens or even hundreds of
genes. We will need new tools that can provide probabi- able for disseminating information to other investiga-
tors. Homology-based reasoning has been a powerfullistic assessments of how well different models of com-
plex genetic regulatory circuitry explain observed data. force in molecular biology to date. Capturing genetic
pathways in computational form will extend this learningSome will argue that although global gene expression
information is valuable, it does not provide a complete device and will likely have a profound impact on our
understanding of how organisms and cells function be-picture of the functions of a cell since proteins are the
molecules that ultimately regulate and carry out cellular cause it will allow us to recognize conserved network
structures within and across species.functions. Indeed, experimental tools that permit effi-
cient systematic assessment of protein levels, modifica- The emergence of a world in which DNA microarrays
allow scientists and physicians to explore and solvetions, and intracellular locations will need to be devel-
oped before the world of functional modules and other biological and medical problems with databases con-
taining shared knowledge faces some formidable prob-aspects of biology can be fully discerned (Pandey and
Mann, 2000). However, two features of expression profil- lems. If the powerful combination of expression profiles
and mathematics is to be fully deployed to model biolog-ing make it the most productive approach to study bio-
logical systems for the immediate future. First, the pres- ical behavior, then very accurate information must be
available. The chief challenges for a database of shared in-ent efficiency with which investigators can obtain global
and quantitative information with DNA arrays exceeds formation involve microarray quality and expense, experi-
mental design, and information handling and analysis.that of proteomic techniques. Second, RNA expression
profiles provide an extremely precise and reproducible
signature of the state of the cell that probably reflects, Technical and Conceptual Challenges
Microarray hardware with sensitive and highly reproduc-albeit indirectly, the functional state of all proteins.
ible performance characteristics is necessary for the
development of valuable databases, particularly thoseDatabases with Collective Knowledge
The development of databases containing expression with collective knowledge on living processes. This will
be especially challenging with the large number of genesprofiles and other information on living processes will
be a valuable asset for scientists involved in basic bio- that exist in mammalian genomes. DNA microarray tech-
nologies are already providing valuable expression in-logical discovery, disease diagnostics, drug develop-
ment and the new fields of research that will develop formation to biologists, but there is significant room
for improvements. It is not yet clear how the variousto explore such information. The biomedical community
is already working to establish standards and expres- microarray technologies will compare when the com-
plete human gene set is arrayed and expression profilession database management systems to permit data
sharing by scientists worldwide (Brazma et al., 2000). are obtained for a variety of different tissues. A direct
Figure 2. Computational Approaches to Classifying and Displaying Patterns in Expression Profile Data
Selected display tools illustrative of current approaches to visualizing expression data are shown. (a) A scatter plot identifies outlying genes
whose expression differs meaningfully between the wild-type yeast and a SIR2 mutant strain (Wyrick et al., 1999). (b) A Venn diagram showing
the relationships among genes affected by mutations in two different yeast transcription factors (TAFII145 and GCN5) when each of the
mutations is present in separate cells or when both mutations are present in cells. The results indicate that many genes are affected in the
double mutant that are unaffected by either single mutant, suggesting functional redundancy between the two transcription factors (Lee et
al., 2000). (c) A screen shot of GeneSpring output (Silicon Genetics) showing expression patterns of all yeast genes over time during a cell
cycle experiment. (d) Multidimensional scaling can illustrate the relative similarity between the expression signatures of different mutant yeast
strains. (e) The GeneCluster program uses self-organizing maps (SOM) to group genes into coexpressed clusters (Tamayo et al., 1999). The
SOM algorithm causes related clusters to be placed into adjacent positions in the grid. (f) Hierarchical cluster analysis of the yeast cell cycle
using a program developed by Eisen et al. (1998). The highlighted cluster shows genes whose expression patterns follow the cell cycle. (g)
A chromosome display of the SIR2 mutant shows the distribution of changes in gene expression across the genome (Wyrick et al., 1999).
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side-by-side comparison of the attributes of these differ- using simple color schemes (Figure 2). Much more so-
ent arrays has yet to be performed. Dynamic range, phisticated approaches are needed to assist scientists
cross-hybridization, reproducibility, and cost must be in the examination and interpretation of expression pro-
assessed. As the size of the genome and amount of file datasets. Perhaps most importantly, it will be valu-
redundancy increase, aspects of array design that pro- able to search for a body of mathematics that will serve
vide the most accurate signal for each gene, such as as a natural language for gene expression information,
the optimal oligonucleotide length needed for high sig- one that parallels the mathematics that works so well
nal-to-noise ratios with minimal cross-hybridization, will to describe physical processes.
have to be identified. It remains to be seen if DNA mi-
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